176 related articles for article (PubMed ID: 33934700)
1. Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation.
Wang Q; Xu L; Dong Y; Fu Y; Pan Y; Luan Q; Liu Y; Liu Z; Yang X; Chen M; Gao Y
BMC Cardiovasc Disord; 2021 May; 21(1):226. PubMed ID: 33934700
[TBL] [Abstract][Full Text] [Related]
2. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease.
Wu XY; Li SN; Wen SN; Nie JG; Deng WN; Bai R; Liu N; Tang RB; Zhang T; Du X; Dong JZ; Ma CS
Europace; 2015 Oct; 17(10):1541-7. PubMed ID: 25921557
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation.
Wang Q; Liu Z; Dong Y; Yang X; Chen M; Gao Y
Front Cardiovasc Med; 2021; 8():813390. PubMed ID: 35141296
[TBL] [Abstract][Full Text] [Related]
4. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
[TBL] [Abstract][Full Text] [Related]
5. Galectin 3 and incident atrial fibrillation in the community.
Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
[TBL] [Abstract][Full Text] [Related]
6. Morphologies of the atria and pulmonary veins in relation to lone atrial fibrillation progression: a dual-source computed tomography scan study.
Liu XP; Xu X; Tian Y; Tang RB; Yu RH; Long DY; Sang CH; Jiang CX; Ning M; Dong JZ; Ma CS
J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S29-35. PubMed ID: 22994909
[TBL] [Abstract][Full Text] [Related]
7. Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis.
Zhang G; Wu Y
Cardiovasc Ther; 2019; 2019():4148129. PubMed ID: 31772609
[TBL] [Abstract][Full Text] [Related]
8. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
[TBL] [Abstract][Full Text] [Related]
9. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
[TBL] [Abstract][Full Text] [Related]
10. The potential regulatory role of hsa_circ_0004104 in the persistency of atrial fibrillation by promoting cardiac fibrosis via TGF-β pathway.
Gao Y; Liu Y; Fu Y; Wang Q; Liu Z; Hu R; Yang X; Chen M
BMC Cardiovasc Disord; 2021 Jan; 21(1):25. PubMed ID: 33421993
[TBL] [Abstract][Full Text] [Related]
11. Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis.
Zuo K; Yin X; Li K; Zhang J; Wang P; Jiao J; Liu Z; Liu X; Liu J; Li J; Yang X
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188747
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation.
Wałek P; Grabowska U; Cieśla E; Sielski J; Roskal-Wałek J; Wożakowska-Kapłon B
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439775
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.
Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Jover E; García-Alberola A; Jara-Rubio R; Martínez CM; Valdés M; Marín F
Sci Rep; 2017 Jan; 7():40378. PubMed ID: 28079145
[TBL] [Abstract][Full Text] [Related]
14. The role of galectin-3 in atrial fibrillation.
Procyk G; Czapla A; Jałocha K; Tymińska A; Grabowski M; Gąsecka A
J Mol Med (Berl); 2023 Dec; 101(12):1481-1492. PubMed ID: 37773454
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.
Kornej J; Schmidl J; Ueberham L; John S; Daneschnejad S; Dinov B; Hindricks G; Adams V; Husser D; Bollmann A
PLoS One; 2015; 10(4):e0123574. PubMed ID: 25875595
[TBL] [Abstract][Full Text] [Related]
16. Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation.
Tang Z; Zeng L; Lin Y; Han Z; Gu J; Wang C; Zhang H
Heart Lung Circ; 2019 Jun; 28(6):923-931. PubMed ID: 29861319
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of Paroxysmal and Persistent Atrial Fibrillation in Patients With New-Onset Atrial Fibrillation.
Igarashi T; Niwano S; Fukaya H; Yoshizawa T; Nakamura H; Fujiishi T; Ishizue N; Oikawa J; Kishihara J; Murakami M; Niwano H; Ako J
Int Heart J; 2016 Sep; 57(5):573-9. PubMed ID: 27581672
[TBL] [Abstract][Full Text] [Related]
18. Predictive risk factors for recurrent atrial fibrillation after modified endoscopic ablation: A 2-year follow-up.
An K; Zhu J; Ma N; Tang M; Mei J
Clin Cardiol; 2018 Mar; 41(3):372-377. PubMed ID: 29480515
[TBL] [Abstract][Full Text] [Related]
19. Electrogram dispersion-guided driver ablation adjunctive to high-quality pulmonary vein isolation in atrial fibrillation of varying durations.
Qin M; Jiang WF; Wu SH; Xu K; Liu X
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):48-60. PubMed ID: 31701626
[TBL] [Abstract][Full Text] [Related]
20. Shortened leukocyte telomere length as a potential biomarker for predicting the progression of atrial fibrillation from paroxysm to persistence in the short-term.
Wang S; Gao Y; Zhao L; Hu R; Yang X; Liu Y
Medicine (Baltimore); 2021 Jun; 100(23):e26020. PubMed ID: 34114988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
